Cargando…
sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy
OBJECTIVE: Leukoaraiosis (LA) refers to white matter lesions of undetermined etiology associated with the appearance and worsening of vascular pathologies. The aim is to confirm an increased frequency and intensity of LA in symptomatic patients with neurovascular pathology compared with asymptomatic...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862435/ https://www.ncbi.nlm.nih.gov/pubmed/35060359 http://dx.doi.org/10.1002/acn3.51502 |
_version_ | 1784655055999205376 |
---|---|
author | da Silva‐Candal, Andrés Custodia, Antia López‐Dequidt, Iria Rodríguez‐Yáñez, Manuel Alonso‐Alonso, Maria Luz Ávila‐Gómez, Paulo Pumar, José M. Castillo, José Sobrino, Tomás Campos, Francisco Iglesias‐Rey, Ramón Hervella, Pablo |
author_facet | da Silva‐Candal, Andrés Custodia, Antia López‐Dequidt, Iria Rodríguez‐Yáñez, Manuel Alonso‐Alonso, Maria Luz Ávila‐Gómez, Paulo Pumar, José M. Castillo, José Sobrino, Tomás Campos, Francisco Iglesias‐Rey, Ramón Hervella, Pablo |
author_sort | da Silva‐Candal, Andrés |
collection | PubMed |
description | OBJECTIVE: Leukoaraiosis (LA) refers to white matter lesions of undetermined etiology associated with the appearance and worsening of vascular pathologies. The aim is to confirm an increased frequency and intensity of LA in symptomatic patients with neurovascular pathology compared with asymptomatic subjects, and its association with circulating serum levels of soluble tumor necrosis factor‐like weak inducer of apoptosis (sTWEAK). METHODS: An observational study was conducted in which two groups of patients were compared. Group I (N = 242) comprised of asymptomatic subjects with arterial hypertension and/or diabetes or with a history of transient ischemic attacks, and Group II (N = 382) comprised patients with lacunar stroke or deep hemispheric intracerebral hemorrhage (ICH) of hypertensive origin. Serum levels of sTWEAK were analyzed and correlated with prevalence and intensity of LA according to the Fazekas scale. RESULTS: The prevalence of LA was higher in symptomatic (85.1%) versus asymptomatic patients (62.0%). Logistic regression model showed a significant relation of LA with neurovascular pathologies (OR: 2.69, IC 95%: 1.10–6.59, p = 0.003). When stratified according to the Fazekas scale, LA of grade II (OR: 3.53, IC 95%: 1.10–6.59, p = 0.003) and specially grade III (OR: 4.66, 95% CI: 1.09–19.84, p = 0.037) showed correlation with neurovascular pathologies. Increased sTWEAK levels were found in the symptomatic group in all LA grades (p < 0.0001), and associated with 5.06 times more risk of presenting clinical symptoms (OR: 5.06, 95% CI: 2.66–9.75, p < 0.0001). INTERPRETATION: LA showed a higher prevalence in patients with symptomatic lacunar stroke or deep hemispheric ICH. There is an association between sTWEAK levels and LA degree. |
format | Online Article Text |
id | pubmed-8862435 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-88624352022-02-27 sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy da Silva‐Candal, Andrés Custodia, Antia López‐Dequidt, Iria Rodríguez‐Yáñez, Manuel Alonso‐Alonso, Maria Luz Ávila‐Gómez, Paulo Pumar, José M. Castillo, José Sobrino, Tomás Campos, Francisco Iglesias‐Rey, Ramón Hervella, Pablo Ann Clin Transl Neurol Research Articles OBJECTIVE: Leukoaraiosis (LA) refers to white matter lesions of undetermined etiology associated with the appearance and worsening of vascular pathologies. The aim is to confirm an increased frequency and intensity of LA in symptomatic patients with neurovascular pathology compared with asymptomatic subjects, and its association with circulating serum levels of soluble tumor necrosis factor‐like weak inducer of apoptosis (sTWEAK). METHODS: An observational study was conducted in which two groups of patients were compared. Group I (N = 242) comprised of asymptomatic subjects with arterial hypertension and/or diabetes or with a history of transient ischemic attacks, and Group II (N = 382) comprised patients with lacunar stroke or deep hemispheric intracerebral hemorrhage (ICH) of hypertensive origin. Serum levels of sTWEAK were analyzed and correlated with prevalence and intensity of LA according to the Fazekas scale. RESULTS: The prevalence of LA was higher in symptomatic (85.1%) versus asymptomatic patients (62.0%). Logistic regression model showed a significant relation of LA with neurovascular pathologies (OR: 2.69, IC 95%: 1.10–6.59, p = 0.003). When stratified according to the Fazekas scale, LA of grade II (OR: 3.53, IC 95%: 1.10–6.59, p = 0.003) and specially grade III (OR: 4.66, 95% CI: 1.09–19.84, p = 0.037) showed correlation with neurovascular pathologies. Increased sTWEAK levels were found in the symptomatic group in all LA grades (p < 0.0001), and associated with 5.06 times more risk of presenting clinical symptoms (OR: 5.06, 95% CI: 2.66–9.75, p < 0.0001). INTERPRETATION: LA showed a higher prevalence in patients with symptomatic lacunar stroke or deep hemispheric ICH. There is an association between sTWEAK levels and LA degree. Blackwell Publishing Ltd 2022-01-21 /pmc/articles/PMC8862435/ /pubmed/35060359 http://dx.doi.org/10.1002/acn3.51502 Text en © 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles da Silva‐Candal, Andrés Custodia, Antia López‐Dequidt, Iria Rodríguez‐Yáñez, Manuel Alonso‐Alonso, Maria Luz Ávila‐Gómez, Paulo Pumar, José M. Castillo, José Sobrino, Tomás Campos, Francisco Iglesias‐Rey, Ramón Hervella, Pablo sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy |
title |
sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy |
title_full |
sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy |
title_fullStr |
sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy |
title_full_unstemmed |
sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy |
title_short |
sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy |
title_sort | stweak is a leukoaraiosis biomarker associated with neurovascular angiopathy |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862435/ https://www.ncbi.nlm.nih.gov/pubmed/35060359 http://dx.doi.org/10.1002/acn3.51502 |
work_keys_str_mv | AT dasilvacandalandres stweakisaleukoaraiosisbiomarkerassociatedwithneurovascularangiopathy AT custodiaantia stweakisaleukoaraiosisbiomarkerassociatedwithneurovascularangiopathy AT lopezdequidtiria stweakisaleukoaraiosisbiomarkerassociatedwithneurovascularangiopathy AT rodriguezyanezmanuel stweakisaleukoaraiosisbiomarkerassociatedwithneurovascularangiopathy AT alonsoalonsomarialuz stweakisaleukoaraiosisbiomarkerassociatedwithneurovascularangiopathy AT avilagomezpaulo stweakisaleukoaraiosisbiomarkerassociatedwithneurovascularangiopathy AT pumarjosem stweakisaleukoaraiosisbiomarkerassociatedwithneurovascularangiopathy AT castillojose stweakisaleukoaraiosisbiomarkerassociatedwithneurovascularangiopathy AT sobrinotomas stweakisaleukoaraiosisbiomarkerassociatedwithneurovascularangiopathy AT camposfrancisco stweakisaleukoaraiosisbiomarkerassociatedwithneurovascularangiopathy AT iglesiasreyramon stweakisaleukoaraiosisbiomarkerassociatedwithneurovascularangiopathy AT hervellapablo stweakisaleukoaraiosisbiomarkerassociatedwithneurovascularangiopathy |